Durability of Double-gloving With Biogel® Surgical Gloves When Used by Clinicians/Surgeons (InDure)

• ClinicalTrials.gov Identifier: NCT03344354
• Recruitment Status: Recruiting
• First Posted: November 17, 2017
• Last Update Posted: July 24, 2020
• Sponsor: Molnlycke Health Care AB
• Information provided by (Responsible Party): Molnlycke Health Care AB

Study Description

Brief Summary:

A prospective open-label study design was chosen because it will provide the most accurate data on the efficacy of four commercially available similar brands of NRL (natural rubber latex) and synthetic latex surgical gloves when they are used for surgeries in a clinical setting. The primary endpoint will be the overall failure rate of the Biogel® sterile surgical undergloves (device) compared to undergloves from Ansell, Medline, and Cardinal brands of surgical gloves. The secondary endpoints are perforation rates of the underglove, the failure rate of the overglove, the frequency of overglove perforation detection by the glove wearer when double-gloving, the ratio of perforations detected of overglove compared to underglove and to determine the frequency of overglove perforation detection by the glove wearer.

The clinical investigation will be statistically powered to test the hypothesis that the failure rate of the Biogel® Sterile Surgical undergloves is different from that of the three comparators.

Condition or disease	Intervention/treatment	Phase
The Perforation Rate of Surgical Gloves	Device: Biogel 1; Device: Ansell; Device: Cardinal; Device: Biogel 2; Device: Medline	Not Applicable

Detailed Description:

This is a non-significant risk, cross-over, comparative, prospective, five-armed, open-label clinical investigation in which the perforation rate of surgical gloves from four different manufacturers will be evaluated in double-gloving fashion. Study clinicians who will directly in the sterile field, with a similar surgical procedural work scope will be asked to use gloves from the four manufacturers of surgical gloves: Molnlycke Health Care, Ansell, Medline, and Cardinal - while performing those surgical procedures. The types of procedures under which the study gloves will be put in use are prosthetic joints arthroplasty and implantation (i.e. orthopedic), trauma surgery, neurosurgery, colorectal and cardiothoracic surgery.

All gloves under evaluation in each phase will be assessed for perforation rate and overall failure on the basis of binomial responses (Y/N) looking at five time points:

• glove failure pre-donning (after removal from pack, prior to donning)
• glove failure during donning (putting the gloves on)
• observed intraoperative glove failure
• glove failure during doffing (glove removal)
• post-procedure: glove perforation and failure determined using a standardized water leak test

No patient data will be assessed.

Study Design

• Study Type: Interventional (Clinical Trial)
• Estimated Enrollment: 10000 participants
• Allocation: Randomized
• Intervention Model: Crossover Assignment
• Intervention Model Description: This is a non-significant risk, cross-over, comparative, prospective, five-armed, open-label clinical investigation in which the failure rate of surgical gloves from four different manufacturers will be evaluated in double-gloving fashion.
• Masking: None (Open Label)
• Primary Purpose: Other
• Official Title: InDure: A Clinical Investigation Comparing the In-Use Durability of Double-gloving With Biogel® Surgical Gloves to Three Comparators
• Actual Study Start Date: April 10, 2018
• Estimated Primary Completion Date: March 31, 2021
• Estimated Study Completion Date: June 30, 2021

Arms and Interventions

Arm	Intervention/treatment
Active Comparator: Biogel 1; Biogel 1 (overglove) sterile surgical glove	Device: Biogel 1; All study surgical gloves will be used during surgical procedures.
Active Comparator: Ansell; Ansell sterile surgical glove	Device: Ansell; All study surgical gloves will be used during surgical procedures.
Active Comparator: Cardinal; Cardinal sterile surgical glove	Device: Cardinal; All study surgical gloves will be used during surgical procedures.
Active Comparator: Biogel 2; Biogel 2 (underglove) sterile surgical glove	Device: Biogel 2; All study surgical gloves will be used during surgical procedures.
Active Comparator: Medline; Medline sterile sergical glove	Device: Medline; All study surgical gloves will be used during surgical procedures.

Outcome Measures

Primary Outcome Measures :

1. Underglove failure rate compared between all competitors [ Time Frame: Procedures that are scheduled to last a minimum of one (1) hour long ]
   To determine and compare the failure rate of the Biogel® natural rubber latex (NRL) and synthetic latex study underglove assortment to all competitors combined as non-Biogel.
2. Underglove failure rate compared to each of the three comparators [ Time Frame: Procedures that are scheduled to last a minimum of one (1) hour long ]
   To determine and compare the failure rate of the Biogel® natural rubber latex (NRL) and synthetic latex study underglove assortment to each of the three comparators.

Secondary Outcome Measures :

1. Underglove perforation rate compared to each of the three comparators comparators separately and combined as non-Biogel. [ Time Frame: Procedures that are scheduled to last a minimum of one (1) hour long ]
   To determine and compare the perforation rate of the Biogel® NRL and synthetic latex study underglove assortment to that of the three comparators separately and combined as non-Biogel.

Eligibility Criteria

• Ages Eligible for Study: 18 Years and older (Adult, Older Adult)
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Criteria

Inclusion Criteria:

All study clinicians, i.e. study glove wearers, must meet all of the following Inclusion Criteria in order to be included in the investigation:

• Must be certified and licensed physician or a clinician in training under supervision in Orthopedic, Neurosurgery, Cardiothoracic, Colorectal or Trauma specialty surgery services or be working in other OR support functions;
• Directly take part in the surgical procedure work within the sterile field;
• Be willing to wear half size larger underglove if recommended by the manufacturer.
• Perform one of the five target procedure groups which is scheduled to last a minimum of 1 hour;
• Be a current employee or active medical staff member with privileges at the institution conducting the clinical investigation;
• Be willing and able to participate in the written user survey and other tasks associated with the clinical investigation and evaluation of the surgical gloves;
• Be willing and able to read, understand and sign the participant information and consent form prior to the initiation of the clinical investigation.

Exclusion Criteria:

All potential study participants who meets any of the following Exclusion Criteria will not be included in the investigation:

• Has had or currently has dermatological or other medical conditions that may prevent proper scrub technique and the use of the sterile study surgical gloves for the duration of the participation in the procedure or the span of time the investigation is to take place;
• Wearing of rings, bracelets, or other jewelry that cannot be removed during glove evaluation;
• Incomplete or absent training on the current clinical investigation plan and study participation responsibilities; and
• Is an employee or staff member of the Sponsor, CRO or any other glove manufacturer; or is an immediate relative of an employee of the Sponsor, CRO or any other glove manufacturer.

Contacts and Locations

Contacts

Contact: David Pham; +46 31 722 30 00; david.pham@molnlycke.com

Locations

United States, Virginia

Virginia Commonwealth University; Recruiting

Richmond, Virginia, United States, 23298

Contact: Michelle Doll, MD 804-828-2121 Michelle.Doll@vcuhealth.org

Principal Investigator: Michelle Doll, MD

Principal Investigator: Gonzalo Bearman, MD

Sponsors and Collaborators

Molnlycke Health Care AB

Investigators

• Principal Investigator: Gonzalo M.L. Bearman, MD, MPH; Virginia Commonwealth University Health
• Principal Investigator: Michelle Doll, MD, MPH; Virginia Commonwealth University Health

More Information

• Responsible Party: Molnlycke Health Care AB
• ClinicalTrials.gov Identifier: NCT03344354
• Other Study ID Numbers: InDure_G016-002
• First Posted: November 17, 2017
• Last Update Posted: July 24, 2020
• Last Verified: July 2020

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: Yes
• Product Manufactured in and Exported from the U.S.: No